Tan reported that FTO was highly expressed in hormone receptor (HR)-negative and HER2-positive BC patients, based on the immunohistochemical staining of specimens from 79 infiltrating ductal breast cancer (IDBC) patients (Tan et al., 2015). This evidence concerns the gene ERBB2 and breast cancer.